A new jasmonic acid stereoisomeric derivative induces apoptosis via reactive oxygen species in human prostate cancer cells

Cancer Letters

Volumn 326, Issue 2, 2012, Pages 199-205

  Russo, Alessandra ^a   Espinoza, C Luis ^b   Caggia, Silvia ^a   Garbarino, Juan A ^b   Peña Cortés, Hugo ^b   Carvajal, T Marcela ^b   Cardile, Venera ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b DEPARTAMENTO DE FÍSICA   (Chile)

Author keywords

Apoptosis; Biotransformations; Jasmonate family; Prostate cancer cells; Reactive oxygen species

Indexed keywords

3 HYDROXY 2 (BUTENYL)CYCLOPENTANE 1 ACETIC ACID; JASMONIC ACID; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER CELL DESTRUCTION; CANCER INHIBITION; CELL GROWTH; CELL TRANSFORMATION; CONTROLLED STUDY; DRUG EFFECT; DRUG STRUCTURE; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROSTATE CANCER;

APOPTOSIS; CYCLOPENTANES; HUMANS; MALE; OXYLIPINS; PROSTATIC NEOPLASMS; REACTIVE OXYGEN SPECIES; STEREOISOMERISM;

EID: 84866880994     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2012.08.025     Document Type: Article

References (52)

1. Jemal A., Tiwari R.C., Murray T., Ghafoor A., Samuels A., Ward E., Feuer E.J., Thun M.J. Cancer statistics. CA Cancer J. Clin. 2004, 54:8-29.
2. Brawley O.W., Barnes S., Parnes H. The future of prostate cancer prevention. Ann. NY Acad. Sci. 2001, 952:145-152.
3. Feldman B.J., Feldman D. The development of androgen-independent prostate cancer. Nat. Rev. Cancer 2001, 1:34-45.
4. Rangel C., Matzkin H., Soloway M.S. Experience with weekly doxorubicin (adriamycin) in hormone-refractory stage D2 prostate cancer. Urology 1992, 39:577-582.
5. Hussain M.H., Pienta K.J., Redman B.G., Cummings G.D., Flaherty L.E. Oral etoposide in the treatment of hormone-refractory prostate cancer. Cancer 1994, 74:100-103.
6. Roth B.J., Yeap B.Y., Wilding G., Kasimis B., McLeod D., Loehrer P.J. Taxol in advanced, hormone-refractory carcinoma of the prostate. A phase II trial of the Eastern Cooperative Oncology Group. Cancer 1993, 72:2457-2460.
7. Surh Y.J. Cancer chemoprevention with dietary phytochemicals. Nat. Rev. Cancer 2003, 3:768-780.
8. Cardile V., Scifo C., Russo A., Falsaperla M., Morgia G., Motta M., Renis M., Imbriani E., Silvestre G. Involvement of HSP70 in resveratrol-induced apoptosis of human prostate cancer. Anticancer Res. 2003, 23:4921-4926.
9. Scifo C., Cardile V., Russo A., Consoli R., Vancheri C., Capasso F., Vanella A., Renis M. Resveratrol and propolis as necrosis or apoptosis inducers in human prostate carcinoma cells. Oncol. Res. 2004, 14:415-426.
10. Yim D., Singh R.P., Agarwal C., Lee S., Chi H., Agarwal R. A novel anticancer agent, decursin, induces G1 arrest and apoptosis in human prostate carcinoma cells. Cancer Res. 2005, 65:1035-1044.
11. Mohanty N.K., Saxena S., Singh U.P., Goyal N.K., Arora R.P. Lycopene as a chemopreventive agent in the treatment of high-grade prostate intraepithelial neoplasia. Urol. Oncol. 2005, 23:383-385.
12. Bonham M., Posakony J., Coleman I., Montgomery B., Simon J., Nelson P.S. Characterization of chemical constituents in Scutellaria baicalensis with antiandrogenic and growth-inhibitory activities toward prostate carcinoma. Clin. Cancer Res. 2005, 11:3905-3914.
13. Barnes S. Role of phytochemicals in prevention and treatment of prostate cancer. Epidemiol. Rev. 2001, 23:102-105.
14. Schwartz G.G., Hulka B.S. Is vitamin D deficiency a risk factor for prostate cancer? (Hypothesis). Anticancer Res. 1990, 10:1307-1311.
15. Flescher E. Jasmonates in cancer therapy. Cancer Lett. 2007, 245:1-10.
16. Kniazhanski T., Jackman A., Heyfets A., Gonen P., Flescher E., Sherman L. Methyl jasmonate induces cell death with mixed characteristics of apoptosis and necrosis in cervical cancer. Cancer Lett. 2008, 271:34-46.
17. Fingrut O., Reischer D., Rotem R., Goldin N., Altboum I., Zan-Bar I., Flescher E. Jasmonates induce nonapoptotic death in high-resistance mutant p53-expressing B-lymphoma cells. Brit. J. Pharmacol. 2005, 146:800-808.
18. Reischer D., Heyfets A., Shimony S., Nordenberg J., Kashman Y., Flescher E. Effects of natural and novel synthetic jasmonates in experimental metastatic melanoma. Brit. J. Pharmacol. 2007, 150:738-749.
19. Carvajal M., Espinoza L., Caggia S., Cardile V., Garbarino J.A., Pena-Cortes H., Russo A. New stereoisomeric derivatives of jasmonic acid generated by biotransformation with the fungus Gibberella fujikuroi affect the viability of human cancer cells. Electron. J. Biotechnol. 2011, 14:15.
20. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
21. Singh N.P., Tice R.R., Stephens R.E., Scheneider E.L. A microgel electrophoresis technique for the direct quantitation of DNA damage and repair in individual fibroblasts cultured on microscope slides. Mutat. Res. 1991, 252:289-296.
22. Baigi M.G., Brault L., Nequesque A., Beley M., Hilali R.E., Gauzere F., Bagrel D. Apoptosis/necrosis switch in two different cancer cell lines: influence of benzoquinone-and hydrogen peroxide-induced oxidative stress intensity, and glutathione. Toxicol. in Vitro 2008, 22:1547-1554.
23. Shi Y. Mechanisms of caspase activation and inhibition during apoptosis. Mol. Cell 2002, 9:459-470.
24. Dumont A., Hehner S.P. TG Hofmann, M. Ueffing, W. Droge, ML Schmitz, Hydrogen peroxide-induced apoptosis is CD95-independent, requires the release of mitochondria-derived reactive oxygen species and the activation of NF-kappaB. Oncogene 1999, 18:747-757.
25. Bednarek I., Sypniewski D., Klama-Baryła A., Gałka S., Machnik G. Single-cell gel electrophoresis (comet assay) as a tool for apoptosis determination in tumor cell lines HL-60 and Jurkat cultures treated with anisomycin. Ann. Acad. Med. 2006, 60:278-284.
26. Godard T., Deslandes E., Lebailly P., Vigreux C., Sichel F., Poul J.M., Gauduchon P. Early detection of staurosporine-induced apoptosis by comet and annexin V assays. Histochem. Cell Biol. 1999, 112:155-161.
27. Callagy G.M., Webber M.J., Pharoah P.D., Caldas C. Meta-analysis confirms Bcl2 is an independent prognostic marker in breast cancer. BMC Cancer 2008, 8:153-163.
28. Loo G. Redox-sensitive mechanisms of phytochemical-mediated inhibition of cancer cell proliferation. J. Nutr. Biochem. 2003, 14:64-73.
29. Wasternack C. Jasmonates: an update on biosynthesis, signal transduction and action in plant stress response, growth and development. Ann. Bot. 2007, 100:681-697.
30. Miersch O., Bohlmann H., Wasternack C. Jasmonates and related compounds from Fusarium oxysporu. Phytochemistry 1999, 50:517-523.
31. Dombrowski J. Salt stress activation of wound-related genes in tomato plants. Plant Physiol. 2003, 132:2098-2107.
32. Stratmann J. Ultraviolet-B radiation co-opts defense signaling pathways. Trends Plant Sci. 2003, 8:526-533.
33. Herman M.A.B., Davidson J.K., Smart C.D. Induction of plant defense gene expression by plant activators and Pseudomonas syringae pv. tomato in greenhouse-grown tomatoes. Phytopathology 2008, 98:1226-1232.
34. Cohen S., Flescher E. Methyl jasmonate: A plant stress hormone as an anti-cancer drug. Phytochemistry 2009, 70:1600-1609.
35. Miersch O., Kramell R., Parthier B., Wasternack C. Structure-activity relations of substituted, deleted or stereospecifically altered jasmonic acid in gene expression of barley leaves. Phytochemistry 1999, 50:353-361.
36. Staswick P. The tryptophan conjugates of jasmonic and indole-3-acetic acids are endogenous auxin inhibitors. Plant Physiol. 2009, 150:1310-1321.
37. Julsing M., Kolman A., Woerdenbag H., Quax W., Kayser O. Combinatorial biosynthesis of medicinal plant secondary metabolites. Biomol. Eng. 2006, 23:265-279.
38. Fraga B.M., Gonzales P., Henandez M., Chamy M.C., Garbarino J. Microbial transformation of 18-hydroxy-9,13-epi-ent-pimara-7,15-diene by Gibberella fujikuroi. J. Nat. Prod. 2003, 66:392-397.
39. Lehman L., Stewart J. Filamentous fungi potentially useful catalysts for the biohydroxylations of non-activated carbon centers. Curr. Org. Chem. 2001, 5:439-470.
40. Boyd D.R., Sharma N., Ljubez V., Byrne B., Shepherd S., Allen C., Kulakov L., Larkin M., Dalton H. Tandem enzyme-catalysed oxidations of alkyl phenyl sulfides and alkyl benzenes: Enantiocomplementary routes to chiral phenols. Chem. Commun. 2002, 17:1914-1915.
41. Arceci R.J. Mechanism of resistance to therapy and tumor survival. Curr. Opin. Hematol. 1995, 2:268-274.
42. Denmeade S.R., Lin X.S., Isaacs J.T. Role of programmed (apoptotic) cell death during the progression and therapy for prostate cancer. Prostate 1996, 28:251-265.
43. Nimmanapalli R., Perkins C.L., Orlando M., O'Bryan E., Nguyen D., Bhalla K.N. Pretreatment with paclitaxel enhances Apo-2 ligand/tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of prostate cancer cells by inducing death receptors 4 and 5 protein levels. Cancer Res. 2001, 61:759-763.
44. Borner M.M., Myers C.E., Sartor O., Sei Y., Toko T., Trepel J.B., Schneider E. Drug-induced apoptosis is not necessarily dependent on macromolecular synthesis or proliferation in the p53-negative human prostate cancer cell line PC-3. Cancer Res. 1995, 53:2122-2128.
45. Fingrut O., Flescher E. Plant stress hormones suppress the proliferation and induce apoptosis in human cancer cells. Leukemia 2002, 16:608-616.
46. Yeruva L., Elegbede J.A., Carper S.W. Methyl jasmonate decreases membrane fluidity and induces apoptosis through tumor necrosis factor receptor 1 in breast cancer cells. Anticancer Drugs 2008, 19:766-776.
47. Jiang G., Zhao J., Xiao X., Tao D., Gu C., Tong Q., Luo B., Wang L., Zeng F. AN N-terminal Smac peptide sensitizes human prostate carcinoma cells to methyl jasmonate-induced apoptosis. Cancer Lett. 2011, 302:37-46.
48. Callagy G.M., Webber M.J., Pharoah P.D., Caldas C. Meta-analysis confirms Bcl2 is an independent prognostic marker in breast cancer. BMC Cancer 2008, 8:153.
49. Krajewski S., Krajewska M., Turner B.C., Pratt C., Howard B., Zapata J.M., Frenkel V., Robertson S., Ionov Y., Yamamoto H., Perucho M., Takayama S., Reed J.C. Prognostic significance of apoptosis regulators in breast cancer. Endocr. Relat. Cancer 1999, 6:29-40.
50. Wochna A., Niemczyk E., Kurono C., Masaoka M., Kedzior J., Slominska E., Lipinski M., Wakabayashi T. A possible role of oxidative stress in the switch mechanism of the cell death mode from apoptosis to necrosis-studies on rho0 cells. Mitochondrion 2007, 7:119-124.
51. Kim J.H., Lee S.Y., Oh S.Y., Han S.I., Park H.G., Yoo M.A., Kang H.S. Methyl jasmonate induces apoptosis through induction of Bax/Bcl-XS and activation of caspase-3 via ROS production in A549 cells. Oncol. Rep. 2004, 12:1233-1238.
52. Ezekwudo D., Shashidharamurthy R., Devineni D., Bozeman E., Palaniappan R., Selvaraj P. Inhibition of expression of anti-apoptotic protein Bcl-2 and induction of cell death in radioresistant human prostate adenocarcinoma cell line (PC-3) by methyl jasmonate. Cancer Lett. 2008, 270:277-285.